Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-02

Clinical Trial Update: Molecular Mechanisms of Mitral Regurgitation-Aim 2

View source ↗

Summary

The update notes that Aim 2 of the study on the molecular mechanisms of mitral regurgitation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Mitral Regurgitation | Status: COMPLETED